TSVT 2seventy bio Inc
Price (delayed)
$4.96
Market cap
$259.6M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.1
Enterprise value
$432.07M
Highlights
TSVT's EPS has surged by 75% year-on-year and by 40% since the previous quarter
The net income has surged by 74% year-on-year and by 39% since the previous quarter
2seventy bio's quick ratio has increased by 18% YoY but it has decreased by 7% from the previous quarter
2seventy bio's gross profit has shrunk by 76% YoY and by 34% QoQ
2seventy bio's revenue has shrunk by 62% YoY and by 17% QoQ
Key stats
What are the main financial stats of TSVT
Market
Valuations
Earnings
Shares outstanding
52.34M
Market cap
$259.6M
Enterprise value
$432.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.21
Price to sales (P/S)
6.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.41
Revenue
$37.86M
Gross profit
$19.85M
Operating income
-$117.85M
Net income
-$57.25M
EBIT
-$57.25M
EBITDA
-$50.15M
Free cash flow
-$85.53M
Per share
Balance sheet
Liquidity
EPS
-$1.1
EPS diluted
-$1.1
Free cash flow per share
-$1.64
Book value per share
$4.09
Revenue per share
$0.73
TBVPS
$9.07
Total assets
$479.51M
Total liabilities
$268.7M
Debt
$243.72M
Equity
$210.81M
Working capital
$147.16M
Debt to equity
1.16
Current ratio
4.67
Quick ratio
4.55
Net debt/EBITDA
-3.44
Margins
Efficiency
Dividend
EBITDA margin
-132.5%
Gross margin
52.4%
Net margin
-151.2%
Operating margin
-311.2%
Return on assets
-11.4%
Return on equity
-26%
Return on invested capital
-9.2%
Return on capital employed
-13%
Return on sales
-151.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TSVT stock price
How has the 2seventy bio stock price performed over time
Intraday
0.2%
1 week
0%
1 month
87.88%
1 year
0.4%
YTD
68.71%
QTD
0.4%
Financial performance
How have 2seventy bio's revenue and profit performed over time
Revenue
$37.86M
Gross profit
$19.85M
Operating income
-$117.85M
Net income
-$57.25M
Gross margin
52.4%
Net margin
-151.2%
2seventy bio's gross profit has shrunk by 76% YoY and by 34% QoQ
The net income has surged by 74% year-on-year and by 39% since the previous quarter
2seventy bio's revenue has shrunk by 62% YoY and by 17% QoQ
2seventy bio's operating income has soared by 50% YoY and by 26% from the previous quarter
Growth
What is 2seventy bio's growth rate over time
Valuation
What is 2seventy bio stock price valuation
P/E
N/A
P/B
1.21
P/S
6.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.41
TSVT's EPS has surged by 75% year-on-year and by 40% since the previous quarter
TSVT's P/B is 21% above its last 4 quarters average of 1.0
The equity has declined by 17% year-on-year and by 8% since the previous quarter
2seventy bio's revenue has shrunk by 62% YoY and by 17% QoQ
TSVT's P/S is 52% above its last 4 quarters average of 4.5
Efficiency
How efficient is 2seventy bio business performance
The ROIC has soared by 69% YoY and by 37% from the previous quarter
2seventy bio's ROA has soared by 65% YoY and by 37% from the previous quarter
The ROE has soared by 60% YoY and by 36% from the previous quarter
TSVT's return on sales is up by 30% year-on-year and by 27% since the previous quarter
Dividends
What is TSVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TSVT.
Financial health
How did 2seventy bio financials performed over time
TSVT's total assets is 78% greater than its total liabilities
2seventy bio's quick ratio has increased by 18% YoY but it has decreased by 7% from the previous quarter
TSVT's current ratio is up by 17% YoY but it is down by 6% from the previous quarter
TSVT's debt is 16% higher than its equity
The equity has declined by 17% year-on-year and by 8% since the previous quarter
2seventy bio's debt to equity has increased by 15% YoY and by 7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.